Profil
Olaf Schröder is associated with NeuroProof GmbH.
He held the position of Chief Executive Officer in the company.
Dr. Schröder is the founder of NeuroProof GmbH, which was founded in 2007.
He held the position of Chief Executive Officer & Director at NeuroProof GmbH since its founding in 2007.
Postes actifs de Olaf Schröder
| Sociétés | Poste | Début |
|---|---|---|
NeuroProof GmbH
 NeuroProof GmbH Information Technology ServicesTechnology Services NeuroProof GmbH provides screening services for pre-clinical development of neuro-pharmaceuticals. It offers phenotypic profiling, cell viability and cytotoxicity, target validation, combination and adjunctive, and data analysis. The company was founded by Olaf Schröder, Alexandra Voß, and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Fondateur | 01/01/2007 |
Anciens postes connus de Olaf Schröder
| Sociétés | Poste | Fin |
|---|---|---|
NeuroProof GmbH /Old/
 NeuroProof GmbH /Old/ BiotechnologyHealth Technology NeuroProof GmbH provides pre-clinical data on the electro-physiological properties of drug candidates for diseases of the central nervous system. Its services include phenotypic profiling, disease models, cell viability & cytotoxicity, target validation, neurogenesis/development, combination & adjunctive therapy, prediction of side effects, stem cells and data analysis. The company was founded by Olaf Schroder, Alexandra Voß and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NeuroProof GmbH /Old/
NeuroProof GmbH /Old/ BiotechnologyHealth Technology NeuroProof GmbH provides pre-clinical data on the electro-physiological properties of drug candidates for diseases of the central nervous system. Its services include phenotypic profiling, disease models, cell viability & cytotoxicity, target validation, neurogenesis/development, combination & adjunctive therapy, prediction of side effects, stem cells and data analysis. The company was founded by Olaf Schroder, Alexandra Voß and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Health Technology |
NeuroProof GmbH
NeuroProof GmbH Information Technology ServicesTechnology Services NeuroProof GmbH provides screening services for pre-clinical development of neuro-pharmaceuticals. It offers phenotypic profiling, cell viability and cytotoxicity, target validation, combination and adjunctive, and data analysis. The company was founded by Olaf Schröder, Alexandra Voß, and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Technology Services |
